细胞重编程可使肿瘤更响应免疫疗法
Cell reprogramming could make tumors more responsive to immunotherapy
瑞典隆德大学领导的一项国际研究发现,通过重编程癌细胞可以组织免疫系统攻击肿瘤,这种方法在多种癌症类型中显示出潜力,可能帮助更多患者受益于免疫疗法。
研究揭示了细胞重编程如何帮助免疫系统更有效地攻击肿瘤,可能为更多患者带来治疗希望。
In a new international study led by Lund University in Sweden, researchers have uncovered how reprogrammed cancer cells can help orchestrate the immune system's attack on tumors. Experiments in mice revealed how immune cells are recruited and organized within tumors to mount an immune response. The findings could pave the way for more effective immunotherapy and, ultimately, help more patients benefit from the treatment.
Immunotherapy is a treatment that helps the body's own immune system fight cancer. The treatment has fundamentally changed cancer care, but it still does not work for everyone—particularly with cancers that are difficult to treat.
Immune clusters help coordinate the attack
An important factor is how well the immune system can organize its attack inside the tumor. There is a process inside certain tumors that forms small clusters of immune cells—known as tertiary lymphoid structures (TLSs)—which help coordinate the immune response.
Patients whose tumors contain these clusters respond better to immunotherapy and often have higher survival rates. But the formation of these clusters requires the right combination of inflammatory signals, immune cells and a tumor environment that allows the immune system to organize itself.
"Until now, it has been complicated to induce the formation of TLSs, because there have been no good methods for studying and engineering these structures in different types of tumors in the laboratory. We have now developed a new strategy to address this challenge," says Filipe Pereira, professor of molecular medicine at Lund University, who led the study published in the journal Immunity.
Reprogramming cancer cells to organize immunity
In previous studies, the research group has shown that cancer cells inside tumors can be reprogrammed into dendritic cells—an important type of immune cell that helps the body mount an antitumor immune response.
"In the new study, we show that these reprogrammed cells can also promote the formation of TLSs."
Using the method of reprogramming tumor cells into dendritic cells, the researchers have now been able to investigate what happens in the tumor tissue when TLSs form. They have also demonstrated how reprogrammed cells contribute to organizing the immune system's attack on the tumor.
Mouse experiments show promise across cancer types
In experiments in mice, the researchers showed that the method can activate the immune system across several different types of cancer, including melanoma, colorectal, bladder, breast and pancreatic cancer.
The results suggest that cell reprogramming could become a way of making tumors more responsive to immunotherapy and, in the long term, help more patients benefit from this treatment.
"Our study shows that this is possible in several cancer types, including tumors that are usually resistant to immunotherapy. It could pave the way for new immunotherapies that make it easier to treat tumors the immune system has previously found difficult to attack," concludes Pereira.
The next step is to better understand which signals cause TLSs to form and persist over time, and how the method can be combined with current immunotherapies. The researchers also want to investigate how different immune cells work together to create a long-lasting response against the tumor.
Publication details
Ervin Ascic et al., Tumor-to-dendritic cell reprogramming induces immunogenic lymphoid structures across cancers, Immunity (2026). DOI: 10.1016/j.immuni.2026.10.006
Journal information: Immunity
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Cell reprogramming could make tumors more responsive to immunotherapy (2026, November 9) retrieved 9 November 2026 from https://medicalxpress.com/news/2026-11-cell-reprogramming-tumors-responsive-immunotherapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com